Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections.
Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, Ray JP, Ko DC, Zou Y, Bang ND, Chau TT, Vary JC, Hawn TR, Dunstan SJ, Farrar JJ, Thwaites GE, King MC, Serhan CN, Ramakrishnan L.
Tobin DM, et al. Among authors: ramakrishnan l.
Cell. 2012 Feb 3;148(3):434-46. doi: 10.1016/j.cell.2011.12.023.
Cell. 2012.
PMID: 22304914
Free PMC article.